Treatment of severe psoriasis with infliximab: report of two cases.

نویسندگان

  • Sandra Peternel
  • Larisa Prpić-Massari
  • Tina Guina
  • Srdan Novak
  • Ines Brajac
  • Marija Kastelan
چکیده

Infliximab is an anti-tumor necrosis factor-monoclonal antibody shown to be effective in the treatment of moderate-to-severe psoriasis and psoriatic arthritis. We report on the first two patients in Croatia in which the efficacy of infliximab therapy was monitored and evaluated primarily on the basis of cutaneous manifestations of psoriasis. Both patients had severe, treatment-resistant chronic plaque psoriasis and psoriatic arthritis and were on methotrexate therapy before the initiation and throughout the course of infliximab treatment. Infliximab was administered intravenously at a dose of 4 or 5 mg/kg at week 0, 2, 6 and every 8 weeks thereafter. Disease severity was measured before each infusion by means of Psoriasis Area and Severity Index (PASI) score. A remarkable clinical response was achieved in both patients with a 50% or greater improvement in baseline PASI at week 2 after therapy initiation and a 90% or greater improvement at week 6 in one patient and at week 14 in the other. Both patients also reported a significant decline in their arthritis symptoms shortly after the introduction of infliximab. The concomitant use of infliximab and methotrexate in these two patients resulted in rapid and sustained remission of psoriasis with no major adverse effects detected.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Peripheral neuropathy during infliximab therapy for rheumatoid arthritis.

Infliximab is a tumor necrosis factor (TNF) alpha antagonist used successfully in the treatment of rheumatoid and seronegative arthritis, Crohn’s disease, psoriasis, and severe cases of vasculitis. Main side effects of this drug are: hypersensitivity syndrome, infections, drug-induced lupus, retrobulbar optic neuritis. Central demyelinating diseases associated with TNFalpha antagonist have been...

متن کامل

Infliximab treatment–induced paradoxical psoriasiform reaction in patient with psoriasis vulgaris showing positive lymphocyte transportation test reaction

IFN-a: interferon alfa LTT: lymphocyte transportation test TNF-a: tumor necrosis factorealfa T umor necrosis factor alfa (TNF-a) antagonists are commonly used to treat inflammatory disorders and are considered particularly effective in the treatment of moderate to severe psoriasis. Paradoxically, however, new-onset occurrence orworsening of psoriasis has been increasingly recognized among patie...

متن کامل

Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series

BACKGROUND Severe psoriasis vulgaris can be extremely difficult to treat in some patients, even with the newer biological therapies available today. CASE PRESENTATIONS We present two patients with severe chronic plaque psoriasis who received numerous systemic anti-psoriatic therapies with varied results. Both responded well to initial treatment with efalizumab (anti-CD11a), but then experienc...

متن کامل

A Case of Severe Panuveitis Associated with Psoriasis Vulgaris Successfully Treated with Infliximab

PURPOSE Uveitis associated with psoriasis vulgaris is usually seen as an anterior segment inflammation, and it is very rare that the inflammation extends to the posterior segment. We herein report a case of severe panuveitis associated with psoriasis vulgaris presenting as retinal neovascularization, leading to vitreous hemorrhages that were successfully treated with infliximab (IFX). CASE RE...

متن کامل

Peripheral neuropathy during Infliximab therapy for rheumatoid arthritis

Infliximab is a tumor necrosis factor (TNF) alpha antagonist used successfully in the treatment of rheumatoid and seronegative arthritis, Crohn’s disease, psoriasis, and severe cases of vasculitis. Main side effects of this drug are: hypersensitivity syndrome, infections, drug-induced lupus, retrobulbar optic neuritis. Central demyelinating diseases associated with TNFalpha antagonist have been...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Acta dermatovenerologica Croatica : ADC

دوره 17 3  شماره 

صفحات  -

تاریخ انتشار 2009